June 5th PROGRAM:
8:15am | MODULE 1 Management of Low-Risk Thyroid Cancer –Observation, RFA or Surgery Chairs: Mike Tuttle and Bryan McIver Rapporteur: Amanda Silver Keynote: Megan Haymart, The role of patient factors in clinical decision making Panel: Akira Miyauchi, Fernanda Vaisman, Laszlo Hegedus, Tracy Wang, Kepal Patel Topics: Preoperative Evaluation (ETE, Nodal Disease), Active Surveillance vs RFA vs Surgery, Patient Centric Outcomes, Hemi vs Total, Adjuvant Therapy – RAI and TSH Suppression, Monitoring / Surveillance 10:45am | MODULE 2 Medullary Thyroid Carcinoma Chairs: Naifa Busaidy and Jeremy Freeman Rapporteur: Nidal Muhanna Keynote: Lori Wirth, RET inhibitor therapy for advanced and metastatic MTC Panel: Jatin Shah, Cherie Ann Nathan, Rossella Elisei, Kerstin Lorenz, Peter Kopp Topics: Preoperative Evaluation/Cytology, Management of Neck Nodes, Monitoring / Surveillance, MEN Syndromes – Genotype Phenotype Correlations, Paraneoplastic Symptoms Management 1:15pm | MODULE 3 The Future of Surgery: IRCAD at the WCTC
Chairs: Jacques Marescaux and Gregory Randolph Rapporteur: Daniel Rocke
Introduction: Imaging, Robotics and Artificial Intelligence, the 3 Weapons of choice to achieve Digital Surgery, Jacques Marescaux, President and Founder of IRCAD
Keynote: Virtual and Augmented Reality applied to Endocrine Surgery, Luc Soler, Former Scientific Director of IRCAD, Professor at the University of Strasbourg
Keynote: Towards Precision Endocrine Neck Surgery with Optical Imaging and Deep Learning, Michele Diana, Medical-Scientific Director of IRCAD Panel: IRCAD Faculty, Ashok Shaha, Brendan Stack, Mike Singer, Teresa Kroeker, Julia Noel, Jeremy Freeman, Ian Witterick Topics: Remote Access Surgery, Robotics, AI, Virtual Surgery – How to Implement and How to Train Each Module will be followed by an Audience Chat, Product Theatre and Virtual Exhibits.
|